Eli Lilly to acquire Ajax Therapeutics for up to $2.3 billion
Eli Lilly to acquire Ajax Therapeutics for up to $2.3 billionhttps://wpnnradio.com/wp-content/themes/movedo/images/empty/thumbnail.jpg150150adminadminhttps://secure.gravatar.com/avatar/790df65a416873c3f0501d984b0b24a2f32bf2af0d1509085b901ade4bbb36e7?s=96&d=mm&r=g
April 27 (Reuters) – Eli Lilly said on Monday it would buy privately-held blood cancer treatment developer Ajax Therapeutics for up to $2.3 billion in cash.
(Reporting by Christy Santhosh in Bengaluru; Editing by Maju Samuel)
